Predictive modeling for pituitary adenomas: single center experience in 501 consecutive patients

PTTG overexpression in non-functioning pituitary adenomas: Correlation with invasiveness, female gender and younger age

(2019) Geraldine Trott et al.   Annals of Diagnostic Pathology

Pre-operative MRI predictors of hormonal remission status post pituitary adenoma resection

(2019) Maria Braileanu et al.   CLINICAL IMAGING

Atypical pituitary adenoma: a clinicopathologic case series

(2018) Martin J. Rutkowski et al.   JOURNAL OF NEUROSURGERY

Clinically Silent Adrenocorticotropic Hormone−Positive Crooke Cell Adenoma: Case Report and Review of Literature

(2018) Nathan Todnem et al.   World Neurosurgery

Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre

(2018) S Asioli et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Both invasiveness and proliferation criteria predict recurrence of non-functioning pituitary macroadenomas after surgery: a retrospective analysis of a monocentric cohort of 120 patients

(2017) Julie Lelotte et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas

(2017) Gerald Raverot et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Outcome of Nonfunctioning Pituitary Adenomas That Regrow After Primary Treatment: A Study From Two Large UK Centers

(2017) Metaxia Tampourlou et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Efficacy of transsphenoidal surgery in achieving biochemical cure of growth hormone-secreting pituitary adenomas among patients with cavernous sinus invasion: a systematic review and meta-analysis

(2017) Vanessa Briceno et al.   NEUROLOGICAL RESEARCH

Comparison of Male and Female Prolactinoma Patients Requiring Surgical Intervention

(2017) Frederick Yoo et al.   Journal of Neurological Surgery Part B-Skull Base

Predictors of aggressive clinical phenotype among immunohistochemically confirmed atypical adenomas

(2016) Hasan A. Zaidi et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Adenomas hipofisarios atípicos: experiencia de 10 años en un centro de referencia de Portugal

(2016) F. Tortosa et al.   NEUROLOGIA

Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients

(2016) Marialaura Del Basso De Caro et al.   NEUROSURGICAL REVIEW

Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study

(2016) Richard N Clayton et al.   Lancet Diabetes & Endocrinology

Invasive, Atypical and Aggressive Pituitary Adenomas and Carcinomas

(2015) Aydin Sav et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline

(2015) Lynnette K. Nieman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Clinicopathological correlates of extrasellar growth patterns in pituitary adenomas

(2015) Sauradeep Sarkar et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Aggressive Pituitary Tumors

(2015) Eleftherios Chatzellis et al.   NEUROENDOCRINOLOGY

Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis

(2015) Sabrina Chiloiro et al.   NEUROENDOCRINOLOGY

Histological criteria for atypical pituitary adenomas – data from the German pituitary adenoma registry suggests modifications

(2015) Christian P. Miermeister et al.   Acta Neuropathologica Communications

Acromegaly: An Endocrine Society Clinical Practice Guideline

(2014) Laurence Katznelson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Management of aggressive pituitary adenomas and pituitary carcinomas

(2014) Anthony Heaney   JOURNAL OF NEURO-ONCOLOGY

Aggressive pituitary adenomas—diagnosis and emerging treatments

(2014) Antonio Di Ieva et al.   Nature Reviews Endocrinology

A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up

(2013) Jacqueline Trouillas et al.   ACTA NEUROPATHOLOGICA

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010

(2013) Q. T. Ostrom et al.   NEURO-ONCOLOGY

Ki-67 Expression for Predicting Progression of Postoperative Residual Pituitary Adenomas: Correlations With Clinical Variables

(2012) Junko MATSUYAMA   NEUROLOGIA MEDICO-CHIRURGICA

Silent Corticotroph Adenomas

(2012) Adriana G. Ioachimescu et al.   NEUROSURGERY

Giant Pituitary Adenomas

(2011) Helen Madsen et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Therapy of aggressive pituitary tumors

(2011) Annamaria Colao et al.   EXPERT OPINION ON PHARMACOTHERAPY

Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline

(2011) Shlomo Melmed et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Silent Corticogonadotroph Adenomas: Clinical and Cellular Characteristics and Long-Term Outcomes

(2010) Odelia Cooper et al.   Hormones & Cancer

Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas

(2008) Roger Gejman et al.   HUMAN PATHOLOGY

Prognostic Significance of the Ki-67 Labeling Index in Growth Hormone-Secreting Pituitary Adenomas

(2008) A. Fusco et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression

(2008) Georg Widhalm et al.   JOURNAL OF NEUROSURGERY